Skip to main content

Table 4 Evidence profile of pre-transplant PFT data (PICO 1)

From: Pulmonary function testing in pediatric allogeneic stem cell transplant recipients to monitor for Bronchiolitis obliterans syndrome: a systematic review

Quality assessment

No. of patients

Result

Quality

Importance

No. of studies

Design

Risk of bias

Inconsistency

Indirectness

Imprecision

Other

Diagnostic yield: FEV1

16

Observational

No serious risk of bias

Serious*

None

None

Possibility of very large percentage of abnormal tests

2200

All with normal FEV1 in 3 studies

Range of prevalence of abnormal: 4–41%. Severe abnormalities: 0–13%

Moderate

Important

Diagnostic yield: FEV1/FVC

13

Observational

No serious risk of bias

Serious*

None

None

Possibility of very large percentage of abnormal tests

909

All with normal FEV1/FVC in 2 studies

Range of abnormalities: 5–20%

Moderate

Important

Diagnostic yield: FEF25-75%

4

Observational

No serious risk of bias

Serious*

None

None

Possibility of very large percentage of abnormal tests

655

Range of abnormalities: 3–28%

Moderate

Important

Diagnostic yield: FVC

10

Observational

No serious risk of bias

Serious*

None

None

Possibility of very large percentage of abnormal tests

1543

All with normal FVC in 2 studies

Range of abnormalities: 10–31%

Moderate

Important

Diagnostic yield: DLCO

10

Observational

No serious risk of bias

Serious*

None

None

Possibility of very large percentage of abnormal tests

914

All with normal DLCO in 1 study.

Range of abnormalities: 3-100%

Moderate

Important

  1. *Wide range of pre-transplant PFT abnormalities across studies